Bristol Myers Squibb reported $110.89B in Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
ALKERMES ALKS:US $ 1995.43M 57.86M
Amgen AMGN:US $ 64993M 5220M
AstraZeneca AZN:LN 107221M 33580M
Astrazeneca AZN:US $ 107221M 33580M
Biogen BIIB:US $ 23806.7M 663.7M
Bristol Myers Squibb BMY:US $ 110893M 96M
Catalent CTLT:US $ 10183M 1071M
Coherus Biosciences CHRS:US $ 741.73M 2.18M
Eli Lilly And LLY:US $ 48187M 378M
Endo International Ordinary Shares ENDP:US $ 9246.55M 40.3M
Gilead Sciences GILD:US $ 67098M 886M
GlaxoSmithKline GSK:LN 78689M 1678M
Gw Pharmaceuticals GWPH:US $ 934.34M 5.17M
Horizon Pharma HZNP:US $ 8608.69M 401.27M
Intercept Pharmaceuticals ICPT:US $ 523.07M 0.15M
JAZZ PHA JAZZ:US $ 12478.15M 734.84M
Lannett LCI:US $ 690.87M 7.13M
Novartis NOVN:VX SF 121209M 2806M
Perrigo Ordinary Shares PRGO:US $ 10915.9M 314.4M
Phibro Animal Health PAHC:US $ 836.04M 5.28M
Prestige Brands PBH:US $ 3675.82M 116.7M
Regeneron Pharmaceuticals REGN:US $ 23671.5M 2185.6M
Revance Therapeutics RVNC:US $ 581.83M 59.05M
Teva Pharmaceutical Industries TEVA:US $ 47851M 1344M
United Therapeutics UTHR:US $ 5048.9M 204M
Zoetis ZTS:US $ 13705M 364M